HOME >> BIOLOGY >> NEWS
Tumor individuality useful for guiding rational chemotherapeutic decisions

A new study describes in detail exactly how the chemotherapeutic drug paclitaxel induces cell death in tumor cells and how common mutations in human tumors confer drug resistance, and demonstrates that combination treatment can restore therapeutic effectiveness of the drug. The research is published in the March issue of the journal Cancer Cell.

When damaged or stressed, normal cells die via a carefully controlled process called apoptosis. In contrast, cancer cells keep dividing, often due to genetic errors that disrupt the mechanisms required to induce apoptosis. Dr. Eileen White from Rutgers University and colleagues examined the role of a molecule called BIM in tumorigenesis and chemotherapeutic response to paclitaxel, a drug that has been used successfully to treat breast, prostate, ovarian, and lung cancers. The researchers examined BIM because it has been implicated as a tumor suppressor and is known to play a role in the regulation of apoptosis.

The researchers found that BIM accumulation is absolutely required for paclitaxel-induced apoptosis, and that BIM deficiency is associated with paclitaxel-resistant tumors. Further research revealed that the H-ras/MAPK signaling pathway suppresses paclitaxel-mediated BIM induction by causing BIM to be targeted for destruction in proteosomes, thereby blocking the ability of BIM to induce apoptosis. Importantly, cotreatment with paclitaxel and a proteosome inhibitor currently approved for use in clinical trials restored paclitaxel-stimulated BIM accumulation and apoptosis that enabled tumor regression.

The H-ras/MAPK pathway is intimately linked to promotion of cell survival and is often abnormally activated during tumorigenesis. The researchers conclude that combinatorial chemotherapy using proteosome inhibitors to enhance chemosensitivity to paclitaxel in tumors where the H-ras/MAPK pathway is activated may be therapeutically beneficial.

These results suggest that a clear underst
'"/>

Contact: Heidi Hardman
hhardman@cell.com
1-617-397-2879
Cell Press
14-Mar-2005


Page: 1 2

Related biology news :

1. Tumor painting revolutionizes fight against cancer
2. Tumor vessels identified by unique molecular markers
3. Tumors stopped from spreading to new sites
4. Chest Tumors -- Prevention, treatment and future perspectives
5. Tumor cells evade death through autophagy
6. Tumor-free breast tissue can have precancerous changes
7. Tumor-suppressor gene is critical for placenta development
8. Tumor response may not be best measure of efficacy in non-small cell lung cancer treatment
9. Tumor cells that border normal tissue are told to leave
10. Tumor suppressor activity of PTEN
11. Scientists seek useful traits in wild cottons

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2018)... ... August 21, 2018 , ... ... of diverse cell types and species for the robust functional interrogation of complex ... the development of T-cell based immunotherapies, the study of the autoimmunity, the understanding ...
(Date:8/21/2018)... FRANCISCO (PRWEB) , ... August ... ... provider of advanced software solutions for biopharma R&D, today announced that Seattle-based ... their preferred bioinformatics solution provider. Aptevo will use the Genedata Biologics ...
(Date:8/17/2018)... ... August 16, 2018 , ... Today, the FSH ... announced that its Colorado Chapter will be holding its 3rd annual Walk & ... at the Philip S. Miller Park, advocates for public awareness and is raising funds ...
Breaking Biology News(10 mins):
(Date:8/17/2018)... ... August 16, 2018 , ... ... pleased to announce the expansion of their team. Dr. Dawn Dufield, Ph.D., joins ... an innovative large molecule LC-MS/MS group that will specialize in developing quantitative LC-MS/MS ...
(Date:8/14/2018)... , ... August 13, 2018 , ... ... chemical fume hoods and biological safety cabinets. In addition, Labconco produces other lab ... one measure of its commitment to quality and consistency in design and manufacturing. ...
(Date:8/11/2018)... ... August 10, 2018 , ... Researchers performing pressurized NMR ... pressure. The Explosion Protection Chamber for High-Pressure NMR & EPR by Wilmad-LabGlass ... safety to the laboratory. , High-pressure experiments have significantly grown in popularity over ...
(Date:8/9/2018)... ... , ... InTouchMD , the leading provider of data services, outreach and ... Biotech Week Boston , September 4th – 7th at Hynes Convention Center in ... most powerful all in one marketing solution. Pulse is a multi-use platform that helps ...
Breaking Biology Technology:
Cached News: